Navigation Links
Study Shows Pine Bark Naturally Reduces Osteoarthritis
Date:4/16/2008

Pycnogenol(R) lowered joint pain by 55 percent from baseline 'severe' to

moderately painful, improved physical function by 56 percent, joint stiffness by 53 percent and increased patients' mobility almost three-fold

HOBOKEN, N.J., April 16 /PRNewswire/ -- More than 20 million Americans suffer from osteoarthritis, with half a million Americans having a total joint replacement each year. A new study to be published in the April 2008 edition (Volume 22, issue No 4) of the journal of Phytotherapy Research shows Pycnogenol(R) (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree, was shown to reduce all osteoarthritis symptoms by 56 percent. The study revealed a particularly high efficacy of Pycnogenol(R) for lowering joint pain by 55 percent. Moreover, patients required dramatically less standard pain medication (-58 percent), which greatly improved the gastrointestinal complications resulting from the pain medication by 63 percent.

"Pycnogenol(R) seemed a natural fit for this study," said Dr. Gianni Belcaro, a lead researcher of the study. "There are a few main components contributing to the clinical picture of treatment management in osteoarthritis: inflammation causing a progression in the disease, alteration of fatigue resistance and muscular performance -- reversing and blocking the vascular problems associated to altered mobility. Theoretically, a treatment with a compound specifically active on all those aspects could be highly effective, which is why we chose Pycnogenol(R)."

The randomized, double-blind, placebo-controlled study, held at Italy's Chieti-Pescara University, sampled 156 patients with osteoarthritis of the knee (OA). Patients were administered 100 mg Pycnogenol(R) or placebo, daily for three months. Symptoms were evaluated by WOMAC index scores and mobility by recording their walking performance on a treadmill. Patients were permitted to continue taking their choice of pain med
'/>"/>

SOURCE Natural Health Science Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Study suggests too much screen time and not enough physical activity may lead to childhood obesity
2. St. Jude gene study reveals basis of anticancer drug resistance in childhood leukemia
3. UAB study shows investigational drug may treat biliary cancers
4. Study shows that high-dose, high-frequency interferon produces no additional benefit
5. Study finds media coverage of breast cancer focuses too little on prevention
6. USC study finds evidence of gender-related differences in development of colon cancer
7. New study in JCSM finds that obesity can predict upper airway obstruction amongst children
8. Study shows increase of hip and knee replacements in the US
9. Study shows decline in work disability due to rheumatoid arthritis
10. Study details cost-effectiveness of rheumatoid arthritis treatments for Medicare recipients
11. Study sheds light on deadly lung disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2008)... Live Web Cast Scheduled for May 19 at 10:15 a.m....tCall/ - Response Biomedical,Corporation (TSX: RBM...,Chief Executive Officer, is scheduled to present ...re Conference on Monday May 19th at 10:15 a.m.,EDT...ailable on the Company,s,Web site at, http://www.r...
(Date:5/16/2008)...t this country needs is more unemployed politician...swire-FirstCall/ -- Although nearly all,voters pla... issues" list,a looming federal budgetary crunch ...y of the current presidential candidates is likely...te Majority Leader Bill Frist., Jousting with Pri...
(Date:5/16/2008)...ONDON, May 16 /PRNewswire/ -- Huntsworth plc (LSE:... relations and healthcare communications,group hea...ent report with,respect to the Group,s performance...h 31, 2008)., The statement follows below., 15... plc, Interim Management Sta...
(Date:5/16/2008)... Appeals for Funds Focus on Millions of Children S...The U.S. Fund for UNICEF and The,Advertising Counc... promote,a series of national public service annou...uding Ben Stiller, Nicole Ritchie, Joel Madden, Da...ed to help survivors of the,Myanmar cyclone. The A...
Breaking Medicine News(10 mins):Health News:Response Biomedical Corporation to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 4Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 3
..., Feinberg School of Medicine have reported in Jou... inactivity and obesity // reduces the cardio-resp...sterol and blood pressure levels leading to increa...ers conducted their survey in U.S. population in t...
...reating psychological disorders. Carl Rogers intro...as been lot of questions about this technique. But... view problems of their patients from a different ...ory to various existing approaches present at that...
.... Zhou, 41 year old factor worker from the Sanming...he seventh victim of bird flu infection in China, ...er and pneumonia. It is not yet known how she got... contact with poultry and moreover she did not tak...
... by rabies which is transmitted through the saliva...ion // is required for a person who is bitten by .... If bite from an animal is unprovoked, it is safe...tested for the infection. If found infected, the a...
Other Medicine News:
(Date:5/16/2008)...., May 16 /- Veridex, LLC announced t...orporation of America Holdings,(LabCorp), has comm...prostate cancer. The new assay uses the biological...er, detecting the methylation of the gene,GST-Pi. ...rimarily in,cancer. Veridex is developing the meth...
(Date:5/15/2008)... Confirm Efficacy for Population Most Affected by ...y 16 /-,Bayer HealthCare Ph...,(Nasdaq: ONXX ) today announced that Nexavar(R) ... survival by 47.3 percent (HR=0.68;,p-value=0.014)...ced,hepatocellular carcinoma (HCC), or primary liv...
(Date:5/15/2008)...O, May 15 /- Medivation, In... an ongoing Phase 1-2 clinical,trial of its novel ...sented,in an oral presentation at the 44th America...ng in Chicago., Session title: New Targeted Str... date and time: Monday, June 2 at 11:30 a.m. Centr...
(Date:5/15/2008)...Presented at ASCO Showed Acceptable Tolerability P...and 4 Neuropathy, WOODCLIFF LAKE, N.J., May 15 /P... agent eribulin mesylate (E7389) demonstrated acti...ith locally advanced or metastatic,breast cancer, ...inical,trial. The study also suggests that eribuli...
Breaking Medicine Technology:Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 2Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 3Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Media highlights in the March 1 issue of Biophysical Journal 2310 1Sunrise Announces Release Date for Fourth Quarter Preliminary Selected Financial and Operating Data 12666 1Doing Angioplasty Long After Heart Attack Still Worth It Analysis Shows 12661 1Doing Angioplasty Long After Heart Attack Still Worth It Analysis Shows 12661 2Stereotaxis Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call 12656 1
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve
Medicine Products: